• Hoth Therapeutics on May 19, 2026 outlined a corporate reorganization that would rebrand the company as Rocket One, pivoting its parent-level strategy toward AI infrastructure, next-generation semiconductors, and ultra-low-power AI computing.
• The shift centers on exclusive licenses to nanomagnetic semiconductor AI acceleration technology and spintronic computing technologies developed at Virginia Commonwealth University, targeting power consumption and computing efficiency constraints in AI data centers.
• Biotechnology programs will continue, with plans to evaluate moving the biotech assets into a separate wholly owned subsidiary to ring-fence the pipeline while the parent pursues AI semiconductor opportunities.
• The board unanimously backed the refocus, with additional license and strategy details slated for disclosure in a Form 8-K filing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hoth Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-060075), on May 21, 2026, and is solely responsible for the information contained therein.